Enchant v3 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

73 results for “Enchant v3”

Trials

View all 49 →

Active, not recruiting

Endurant CHevAr New Indication Trial: ENCHANT

150 participants · First posted Oct 25, 2017

ANGIOPREDICT. ICORG 12-16, V3

76 participants · First posted Apr 2, 2013

CharactHer. ICORG 12-09, V3

130 participants · First posted Nov 7, 2012

Drugs

V3-X

V3-Myoma

V3-P

Organizations

Messer Merchant Production LLC

United States

ORIENTAL MERCHANT PTY. LTD.

Australia

News

View all 13 →

AbbVie and Iambic Launch Multi-Year AI Collaboration for Small Molecule Discovery in Immunology, Neuroscience and Oncology

DiMe and FDA Collaboration Provides Roadmap for Validating Novel Digital Clinical Measures

Single-Dose HIV Vaccine Candidate Induces Neutralizing Antibodies in Nonhuman Primates

Page 1 of 8